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The apoptotic nature of cells treated with compound 10 can be seen in 






























Figure 4. The effects of 10 on MDA-MB-231 cells after 48 h. Images were viewed at 
10 x magnification using light microscopy. A) 10 at 50 µM; B) 10 at 10 µM; C) healthy 
untreated control cells. 
 
AChE inhibition 
AChE inhibitors are currently the front line of drugs used for relieving the 
symptoms of Alzheimer’s disease. Inhibition  properties were assessed 
using the TLC bioautograph4 and Ellman5 assays. This library of compounds 
showed only a few compounds with weak inhibition activity at the 
maximum tested concentration and therefore do not make viable AChE 
inhibitors. Computer aided drug design is currently being used to develop 












The biological activities of several alkaloid-like compounds containing the 3-
aza-bicyclo[3.3.1]nonane core structure (1) have been investigated due to 
the prevalence of this structure in several bio-active natural products, such 





Figure 1. 3-aza-bicyclo[3.3.1]nonane core structure and Aristotelia alkaloids. 
 
The 3-aza-bicyclo[3.3.1]nonane architecture was achieved synthetically via 
the bridged Ritter reaction between (-)-β-pinene (5) and various nitriles. This 
reaction generates optically pure imino amides (6) imino alkenes (7) and 
imino alcohols (8) in a single step.2 In addition to using a wide range of 
nitriles to vary the –R functionality, several derivatisation reactions were also 


















Scheme 1. The general scheme for bridging Ritter reaction with (-)-β-pinene and 
nitriles of functionality –R, with subsequent derivatisation. 
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Of the 35 compounds 
submitted for in silico 
screening, 21 passed and 
were submitted for in vitro 
screening. The results 
currently obtained are 
shown in Figure 5. Most 
significant is the 72.6 % 
inhibition of IL-17 secretion 




A library of 35 alkaloid-like compounds was successfully synthesised, isolated 
and characterised, most of which were then assessed for their biological 
properties. The acetylcholine esterase (AChE) inhibition properties and 
cytotoxicity against the MDA-MB-231 breast cancer cell line were screened 
in-house, while broad screening against therapeutic targets in areas including 
oncology, neuroscience, endocrine/cardiovascular, diabetes and immunology 
and musculoskeletal, is currently being undertaken through the Lilly open 
innovation drug discovery program. 
2.2 Biology 
Cytotoxic activity 
Cytotoxicity against MDA-MB-231 cells was assessed using the MTS assay.3 
Initial screening showed that three compounds caused significant reduction 
in cell viability (Figure 2). The IC50 values for these three compounds was also 






































































































































































































































All positive OIDD results 
Compound SW05 Compound SW06 Compound SW16
Compound SW19 Compound SW22
